Assessing the health outcomes, productivity gains, and budget impact of anti-PD-(L)1’s in the early stages of cancer treatment in Greece

Nikolaos Themistoklis Yfantopoulos, Panagiota Naoum, Anastasios Skroumpelos, Antonis Karokis, Demet Sönmez, Raquel Aguiar-Ibañez, Vivek Khurana, Anastasios Boutis, Michail Liontos, Zacharenia Saridaki, Kostas Athanasakis

Open source

DOI
10.3389/fonc.2026.1814460
Published
2026-08-19
Container
Frontiers in Oncology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1814460,
  title = {Assessing the health outcomes, productivity gains, and budget impact of anti-PD-(L)1’s in the early stages of cancer treatment in Greece},
  author = {Nikolaos Themistoklis Yfantopoulos and Panagiota Naoum and Anastasios Skroumpelos and Antonis Karokis and Demet Sönmez and Raquel Aguiar-Ibañez and Vivek Khurana and Anastasios Boutis and Michail Liontos and Zacharenia Saridaki and Kostas Athanasakis},
  year = {2026},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2026.1814460},
  url = {https://doi.org/10.3389/fonc.2026.1814460}
}

RIS

TY  - JOUR
TI  - Assessing the health outcomes, productivity gains, and budget impact of anti-PD-(L)1’s in the early stages of cancer treatment in Greece
AU  - Nikolaos Themistoklis Yfantopoulos
AU  - Panagiota Naoum
AU  - Anastasios Skroumpelos
AU  - Antonis Karokis
AU  - Demet Sönmez
AU  - Raquel Aguiar-Ibañez
AU  - Vivek Khurana
AU  - Anastasios Boutis
AU  - Michail Liontos
AU  - Zacharenia Saridaki
AU  - Kostas Athanasakis
PY  - 2026
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1814460
UR  - https://doi.org/10.3389/fonc.2026.1814460
ER  - 

APA

Yfantopoulos, N. T., Naoum, P., Skroumpelos, A., Karokis, A., Sönmez, D., Aguiar-Ibañez, R., Khurana, V., Boutis, A., Liontos, M., Saridaki, Z., & Athanasakis, K. (2026). Assessing the health outcomes, productivity gains, and budget impact of anti-PD-(L)1’s in the early stages of cancer treatment in Greece. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1814460

Source records